Rocket Lab shares plunge after Neutron launch delayed to 2027
+1 new source since this summary was written
Rocket Lab announced that the inaugural flight of its medium‑lift Neutron rocket has been pushed back to 2027 because of a manufacturing defect in the forward propellant dome. The news sent the stock down about 64% from its May peak, closing at $54.73 on Oct. 30. The company also disclosed Q2 2026 revenue of $234.1 million, a 62% increase year over year, and a backlog that rose 137% to $2.36 billion.
Why it matters
Citizens analysts lowered their price target to $90, citing the delay as a timing issue but keeping a Market Outperform rating, which may influence investor expectations for the stock. The share price decline reduces market value by roughly $57 billion, affecting existing shareholders and potentially limiting the company’s ability to raise capital in the near term.
Key facts
- 1Rocket Lab’s shares closed at $54.73 on Oct. 30, a drop of about 64% from the May high of $151. tech-insider.org
- 2The company moved the first Neutron launch from Q4 2026 to 2027 after identifying defects in the forward propellant dome of the first stage. tech-insider.org
- 3Q2 2026 revenue was $234.1 million, representing a 62% year‑over‑year increase. tech-insider.org
- 4The backlog grew 137% to $2.36 billion. tech-insider.org
- 5Citizens reiterated a Market Outperform rating with a $90 price target, down from $130, after the delay. investing.com
- 6Rocket Lab successfully launched its 98th Electron mission, deploying three satellites for HawkEye 360. investing.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.